Sign in to view content

Becoming a Clinical Trialist

Nancy M. Holekamp, MD, FASRS

Video
Published 2022

Related

APX3330, an Oral Drug in Trial for DR and DME, Demonstrated a Favorable Safety and Tolerability Profile in Multiple Phase 1 and 2 Studies
Michael J Allingham, MD, PhD
Annual Meeting Talks
2021
Types of Strokes Seen in Patients
Sophie Jane Bakri, MD
Updates from the Field
2017
Development of a Novel Retinal Tamponade Agent to Replace Fluorinated Gas and Silicone Oil
James A Stefater, MD, PhD
Annual Meeting Talks
2019

Category: Practice Management

See more